WCN26-3061 THROMBINURIA AS A MARKER OF INFLAMMATORY ACTIVITY IN GLOMERULONEPHRITIS: A CROSS-SECTIONAL STUDY

Read full text Summarise with VIRAT
Authors: I. S. Mykhaloiko
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Glomerulonephritis (GN) comprises a heterogeneous group of kidney disorders driven by immune-mediated inflammation and structural injury within the glomeruli. Thrombin, a serine protease central to both coagulation and inflammation, has emerged as a potential mediator of glomerular damage. Beyond its role in clot formation, thrombin activates protease-activated receptors (PARs), promoting pro-inflammatory, pro-coagulant, and profibrotic cascades within renal tissue. Despite its biological plausibility, the utility of thrombin as a clinical biomarker in GN remains underexplored.

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Vasculitis and related conditions Blood Coagulation and Thrombosis Mechanisms

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
106190–106190
Publication date
25 March 2026
Language
EN